SCHEMBL5589359

SCHEMBL5589359

CCCc1cc(O)c(O)c(C(=O)O)c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.49
PTPN11 Q06124 2/20 0.49
PRKCI P41743 1/20 0.42
LDHA P00338 3/20 0.41
LDHB P07195 3/20 0.41
MCL1 Q07820 4/20 0.41
BID P55957 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
KAT5 Q92993 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
PTPN2 P17706 2/20 0.40
CNR2 P34972 1/20 0.40
LTB4R Q15722 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587743 0.92 BID (0.49) MCL1BIDBCL2L1BAK1KAT8
SCHEMBL5587936 0.89 FABP4 (0.43) PTPN1PTPN11MCL1BIDBCL2L1
Ethane SCHEMBL28001692 0.81 CNR2 (0.38) PTPN1PTPN11PRKCICNR2
SCHEMBL5587777 0.76 BCL2L1 (0.51) MCL1BCL2L1BAK1PPARG
SCHEMBL5678031 0.76 PTPN1 (0.56) PTPN1PTPN11PRKCILDHALDHB
SCHEMBL5588619 0.76 PTPN1 (0.56) PTPN1PTPN11PRKCILDHALDHB
SCHEMBL5589186 0.76 LDHA (0.50) PTPN1PTPN11LDHALDHBMCL1
SCHEMBL5676847 0.75 PTPN1 (0.54) PTPN1PTPN11PRKCILDHALDHB
SCHEMBL5586755 0.73 LDHA (0.51) LDHALDHBPPARGJUN
SCHEMBL5588016 0.73 LDHA (0.48) PTPN1PTPN11LDHALDHBPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PTPN1 4679/4885PTPN11 4354/4885PRKCI 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.